Abhishek Srivastava

2 years ago By Ben Parkes

Session – Addressing challenges in TCR and CAR-T manufacturing with standardized characterization Abhishek Srivastava is Senior Director, Immunotherapy at Axis Therapeutics, overseeing manufacturing and technical operations of the T cell programs. He has extensive clinical and translational research experience in the field of adoptive T cell therapies serving both academia and industry. Most recently, he was an Assistant Professor (Research) at the Division of Surgical Oncology at the University of Pittsburgh where he led the process development and manufacturing of Tumor Infiltrating Lymphocytes (TIL) to support the multiple adoptive cell therapy Phase II clinical trials. He received his postdoctoral training from Surgery Branch at the National Cancer and earned his Ph.D. in Immunology.  He has authored numerous papers including research articles, abstracts, book chapter and expert opinions

More news